Dick's has been the most publicly prominent among the retailers about the subject of firearms sales, CNN reports.

J.P. Morgan lowers its rating on the stock of the manufactured food company to underweight from neutral.

Working capital lets a business know where it stands in terms of assets and liabilities.

Endo's stock price surges after the company announces a settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in state court in October.

Home Depot's earnings beat analysts' forecasts, though the company indicated future earnings growth may look slightly less solid.

Stocks are down Tuesday as investors take a step back from Wall Street's recent rebound to digest the earnings report from Home Depot and prepare for a flurry of activity from the Federal Reserve.

Bruce's resume includes a number of finance-related roles at Big G as well as tenures at Ford Motor and Ecolab.

In its rejection of golodirsen, Sarepta's second treatment for Duchenne muscular dystrophy, the FDA cites concerns over infection risk 'related to intravenous infusion ports and renal toxicity,' the company says.

Such a bid would be almost 28% higher than Monday's closing price of $28.21 for Hilton Grand Vacations.

Elanco says the deal, which is subject to approval from regulators, would double the size of its companion animal business.

Department store chain Kohl's reports second-quarter earnings lower than a year ago but still ahead of analysts' forecasts as it continues to focus on cutting costs and changing its product lineup.

Shares of the plant-based meat maker surge after analysts at J.P. Morgan upgrade their weighting on the stock, noting its shares are 'appealing once again' following a near-40% drop since the end of July.

Discount clothing and home decor chain TJX posts strong fiscal second-quarter earnings as consumers continue to flock to its TJ Maxx and Marmaxx-branded stores in search of what the company itself calls the 'treasure hunt' shopping experience, though lower guidance pushes its stock lower.

Separately, former CEO Bruce Linton says he is still buying shares of the cannabis company.

There has been an EpiPen shortage in the U.S., Europe and Canada, thanks to manufacturing delays at Pfizer.